Suven Life Sciences Q2 net up 20 percent to Rs 32 crore
New Delhi: Suven Life Sciences reported a 19.5 percent increase in net profit to Rs 31.74 crore for the second quarter ended September 30.
The company had posted a net profit of Rs 26.55 crore in the same quarter last fiscal, Suven Life Sciences said in a regulatory filing to stock exchanges.
Total income during the quarter under review declined to Rs 119.99 crore, as against Rs 122.30 crore in the corresponding period last fiscal, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd